Inflammation and Alzheimer's disease
Inflammation clearly occurs in pathologically vulnerable regions of the Alzheimer’s disease (AD)
brain, and it does so with the full complexity of local peripheral inflammatory responses. …
brain, and it does so with the full complexity of local peripheral inflammatory responses. …
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Objective To quantify the effectiveness of pharmacological and lifestyle interventions to
prevent or delay type 2 diabetes in people with impaired glucose tolerance. Data sources …
prevent or delay type 2 diabetes in people with impaired glucose tolerance. Data sources …
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
…, DJ Mcshane, JF Fries, NS Cooper… - … : Official Journal of …, 1988 - Wiley Online Library
The revised criteria for the classification of rheumatoid arthritis (RA) were formulated from a
computerized analysis of 262 contemporary, consecutively studied patients with RA and 262 …
computerized analysis of 262 contemporary, consecutively studied patients with RA and 262 …
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working …
Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely
dependent on clinical expertise and observations more than on evidence derived from clinical …
dependent on clinical expertise and observations more than on evidence derived from clinical …
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a …
…, CL Hibbert, A Truesdale, F Clemens, N Cooper… - The Lancet, 2009 - thelancet.com
… 766 patients were screened; 180 were enrolled and randomly allocated to consideration
for treatment by ECMO (n=90 patients) or to receive conventional management (n=90). 68 (75%…
for treatment by ECMO (n=90 patients) or to receive conventional management (n=90). 68 (75%…
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
Cryoglobulinemia—a clinical and laboratory study: II. Cryoglobulins with rheumatoid factor activity
…, EC Franklin, K Elias, RT McCluskey, N Cooper - The American journal of …, 1966 - Elsevier
Detailed clinical and laboratory studies of twelve subjects with cryoglobulins associated with
rheumatoid factor activity are presented. These patients constituted 41 per cent of twenty-…
rheumatoid factor activity are presented. These patients constituted 41 per cent of twenty-…
[HTML][HTML] Measuring the Chern number of Hofstadter bands with ultracold bosonic atoms
… Here annihilates (creates) a particle on site (m, n), where the position in the lattice is defined
as , with m, n integers and the unit vectors. In the limit Δ ≫ κ, the effective coupling strengths …
as , with m, n integers and the unit vectors. In the limit Δ ≫ κ, the effective coupling strengths …
[HTML][HTML] Tocilizumab in hospitalized patients with severe Covid-19 pneumonia
Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …